# A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

> **NCT04729621** · PHASE3 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 332 (actual)

## Conditions studied

- Osteoporosis, Postmenopausal

## Interventions

- **COMBINATION_PRODUCT:** TVB-009
- **COMBINATION_PRODUCT:** Prolia®

## Key facts

- **NCT ID:** NCT04729621
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-22
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-06-19
- **Target enrollment:** 332 (ACTUAL)
- **Last updated:** 2024-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04729621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04729621, "A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04729621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*